文章基本信息

标题：Risks in the Drug Procurement System: Current Issues
本地全文：下载
作者：Natalia Alekseevna PRODANOVA ; Usman Salmanovich ZHAUBATYROV ; Elena Ivanovna ZATSARINNAYA 等
期刊名称：Propósitos y Representaciones
印刷版ISSN：2307-7999
电子版ISSN：2310-4635
出版年度：2021
卷号：9
期号：SPE3
页码：1144-1149
DOI：10.20511/pyr2021.v9nSPE3.1144
出版社：Universidad San Ignacio de Loyola
摘要：The public procurement segment is one of the components of the pharmaceutical market in Russia. Procurement of medicines and medical devices is the top sector of public procurement, both in terms of their number and the amount of contracts concluded. The procedure for concluding state contracts itself is spelled out in sufficient detail in the regulatory documents, but, despite this, risks may arise when concluding a state contract both for a potential applicant for a state order and for a state customer. The purpose of the study is to determine the possible risks when concluding a state contract of a healthcare institution for medicines and medical devices and ways to reduce them.
其他摘要：The public procurement segment is one of the components of the pharmaceutical market in Russia. Procurement of medicines and medical devices is the top sector of public procurement, both in terms of their number and the amount of contracts concluded. The procedure for concluding state contracts itself is spelled out in sufficient detail in the regulatory documents, but, despite this, risks may arise when concluding a state contract both for a potential applicant for a state order and for a state customer. The purpose of the study is to determine the possible risks when concluding a state contract of a healthcare institution for medicines and medical devices and ways to reduce them.
其他关键词：risk; state contract; medicines (drugs); public procurement system; procurement procedures; compliance control; pharmaceutical companies